US Patent

US9084778 — Topical compositions containing a retinoid of the oil-in-water emulsion type

Method of Use · Assigned to Galderma Research and Development SNC · Expires 2033-05-30 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method of using a retinoid in a specific type of topical composition, such as in cosmetics or dermatology.

USPTO Abstract

A composition in the form of an oil in water emulsion, preferably without emulsifier, is described. The composition can include, in a physiologically acceptable environment, at least one new retinoid. Also described, is the method of preparing the composition and its use in cosmetics and dermatology.

Drugs covered by this patent

trifarotene (TRIFAROTENE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-134`	—	trifarotene

Patent Metadata

Patent number: US9084778
Jurisdiction: US
Classification: Method of Use
Expires: 2033-05-30
Drug substance claim: No
Drug product claim: Yes
Assignee: Galderma Research and Development SNC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.